STOCK TITAN

Camden Natl Corp SEC Filings

CAC Nasdaq

Welcome to our dedicated page for Camden Natl SEC filings (Ticker: CAC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Camden National Corporation’s 10-K may span hundreds of pages detailing net interest margin shifts, credit-loss allowances, and branch-level deposit data—exactly the material analysts need but rarely have time to unpack. If you have ever searched “Where can I find a Camden National quarterly earnings report 10-Q filing?” or wondered how to monitor Camden National Corporation insider trading Form 4 transactions, you know the challenge of navigating raw EDGAR documents.

Stock Titan solves that problem. Our AI reads every submission the moment it hits EDGAR, from routine 8-K updates to the full Camden National annual report 10-K simplified. It then delivers plain-language summaries, highlights key ratios, and flags risk factors—so you can understand Camden National SEC documents with AI instead of sifting through boilerplate. Need real-time alerts? Get every Camden National Form 4 insider transactions real-time notification, plus quick takes on dividend declarations and loan-portfolio shifts disclosed in 8-Ks (Camden National 8-K material events explained).

Use cases are practical: track Camden National executive stock transactions Form 4 before market moves, compare net charge-offs across periods using our Camden National earnings report filing analysis, or review the Camden National proxy statement executive compensation summary without hunting through exhibits. All filings—10-Q, 10-K, Form 4, DEF 14A—update in real time and come with AI-powered commentary that explains changing interest-rate sensitivity and capital ratios in simple terms. Stop scrolling EDGAR and start focusing on decisions; our platform turns Camden National SEC filings into actionable insight.

Rhea-AI Summary

Camden National Corporation announced a quarterly cash dividend of $0.42 per share in a press release dated September 30, 2025. The dividend is payable on October 31, 2025 to shareholders of record as of October 15, 2025. This filing communicates the company’s distribution of earnings to shareholders and the specific payment and record dates investors need to note if they plan to receive the payment. The notice does not disclose the aggregate payout amount, changes to prior dividends, or any update to capital policy in this item.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.09%
Tags
current report
-
Rhea-AI Summary

Camden National Corporation director Maxwell Raina acquired 357 shares of Camden National Corp common stock on 09/19/2025 at a price of $40.22 per share under the company’s 2022 Equity and Incentive Plan in lieu of director fees. Following the transaction, Raina beneficially owns 2,136.359 shares, a total that includes 19.758 shares added via the company’s dividend reinvestment program since the last filing. The Form 4 was filed individually and signed by a POA on 09/23/2025. The filing discloses a routine equity grant and dividend reinvestment activity by a director.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Lawrence J. Sterrs, a director of Camden National Corporation (CAC), reported a purchase of company common stock. On 09/19/2025 he acquired 195 shares at $40.22 per share under the company's 2022 Equity and Incentive Plan in lieu of director fees. After the transaction he beneficially owned 14,565.066 shares in total, which includes 18.468 shares added since the last filing through the company's dividend reinvestment program. The Form 4 was filed as a single reporting person and signed by a power of attorney on 09/23/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Camden National Corporation (CAC) director Larry K. Haynes acquired common stock on 09/19/2025. The Form 4 reports an acquisition of 357 shares at a price of $40.22 per share under the company's 2022 Equity and Incentive Plan and amendment in lieu of director fees. Following the transaction, Mr. Haynes beneficially owns 2,506.43 shares, which includes 22.032 shares received through the company’s dividend reinvestment program since the prior filing. The filing is a single-person Form 4 and was signed by a POA on 09/23/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

McCarthy Marie J, a director of Camden National Corp (CAC), acquired 372 shares of the company's common stock on 09/19/2025 at $40.22 per share under the company's 2022 Equity and Incentive Plan in lieu of director fees. Following the transaction, McCarthy beneficially owned 15,578.112 shares, which includes 168.238 shares added via the company's dividend reinvestment program since the last filing. The Form 4 was signed by a POA on 09/23/2025. The filing documents a routine equity award and dividend reinvestment activity by an insider rather than an open-market purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Carl John Soderberg, a director of Camden National Corporation (ticker: CAC), reported an acquisition of 394 common shares on 09/19/2025 at a price of $40.22 per share. The shares were issued under the Company’s 2022 Equity and Incentive Plan and were granted in lieu of director fees. Following the transaction, Soderberg beneficially owns 100,419.243 shares. The filing notes that 1,114.364 of those shares were acquired since the last filing through the company’s dividend reinvestment program.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Rebecca Hatfield, a director of Camden National Corporation (CAC), acquired 245 shares of the issuer's common stock on 09/19/2025 at a price of $40.22 per share. The purchase was made under Camden National Corporation's 2022 Equity and Incentive Plan and was issued in lieu of director fees. Following the transaction, the filing reports 7,177.06 shares beneficially owned by the reporting person. The Form 4 was signed by a power of attorney, Christopher G. Hutchinson, on 09/23/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.2%
Tags
current report

FAQ

What is the current stock price of Camden Natl (CAC)?

The current stock price of Camden Natl (CAC) is $38.46 as of October 8, 2025.

What is the market cap of Camden Natl (CAC)?

The market cap of Camden Natl (CAC) is approximately 652.4M.
Camden Natl Corp

Nasdaq:CAC

CAC Rankings

CAC Stock Data

652.45M
16.57M
1.78%
73.89%
2.76%
Banks - Regional
National Commercial Banks
Link
United States
CAMDEN